Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA.
Department of Biology, Texas A&M University, College Station, Texas, USA.
J Neurotrauma. 2023 Dec;40(23-24):2487-2499. doi: 10.1089/neu.2023.0264. Epub 2023 Sep 28.
Spinal cord injury (SCI) affects millions of people worldwide. Neural progenitor cell (NPC) transplantation is a promising treatment for regenerating lost spinal cord tissue and restoring neurological function after SCI. We conducted a literature search and found that less than a quarter of experimental rodent cell and tissue transplantation studies have investigated anatomical outcomes at longer than 4 months post-transplantation. This is a critical topic to investigate, given that stem and progenitor cell therapies would need to remain in place throughout the lifetime of an individual. We sought to determine how commonly assessed anatomical outcomes evolve between early and far chronic time-points post-NPC transplantation. At either 8 weeks or 26 weeks following transplantation of NPCs into sites of cervical SCI, we evaluated graft neuronal density, astroglial cell density, graft axon outgrowth, and regeneration of host axon populations into grafts in male and female mice. We found that graft neuronal density does not change over time, but the numbers of graft-associated astrocytes and glial fibrillary acidic protein intensity is significantly increased in the far chronic phase compared with the early chronic time-point. In addition, graft axon outgrowth was significantly decreased at 26 weeks post-transplantation compared with 8 weeks post-transplantation. In contrast, corticospinal axon regeneration into grafts was not diminished over time, but rather increased significantly from early to far chronic periods. Interestingly, we found that graft neuronal density is significantly influenced by sex of the host animal, suggesting that sex-dependent processes may shape graft composition over time. Collectively, these results demonstrate that NPC transplants are dynamic and that commonly assessed outcome measures associated with graft efficacy evolve over the weeks to months post-transplantation into the spinal cord.
脊髓损伤 (SCI) 影响着全球数百万人。神经祖细胞 (NPC) 移植是一种有前途的治疗方法,可用于再生失去的脊髓组织并恢复 SCI 后的神经功能。我们进行了文献检索,发现不到四分之一的实验性啮齿动物细胞和组织移植研究在移植后超过 4 个月时调查了解剖学结果。鉴于干细胞和祖细胞疗法需要在个体的整个生命周期内保持原位,这是一个需要深入研究的关键课题。我们试图确定 NPC 移植后早期和远慢性时间点之间常见的评估解剖学结果如何演变。在 NPC 移植到颈 SCI 部位后的 8 周或 26 周,我们评估了移植物神经元密度、星形胶质细胞密度、移植物轴突生长以及宿主轴突向移植物的再生情况,分别在雄性和雌性小鼠中进行。我们发现,移植物神经元密度不会随时间变化,但远慢性期与早期慢性时间点相比,移植物相关星形胶质细胞和神经胶质纤维酸性蛋白强度的数量显著增加。此外,与移植后 8 周相比,移植后 26 周移植物轴突生长明显减少。相比之下,皮质脊髓轴突向移植物的再生并没有随时间减少,而是从早期到远慢性阶段显著增加。有趣的是,我们发现移植物神经元密度受到宿主动物性别的显著影响,这表明性别相关的过程可能会随时间改变移植物的组成。总的来说,这些结果表明 NPC 移植是动态的,与移植物功效相关的常见评估指标在移植到脊髓后的数周到数月内会发生演变。